Skip to main content
. 2017 Oct 2;216(10):3051–3060. doi: 10.1083/jcb.201703201

Figure 1.

Figure 1.

BICD2FL activation by Rab6aGTP. (A) Domain architecture of mammalian Bicaudal D2. N188T, I189F, and S107L are mutations associated with human SMA-LED, and F739I is the analogous mutation to the classical Drosophila mutation F684I. Amino acids 400 and 594 indicate the end of constructs used in this study. (B) Porcine brain lysate pull-down using full-length (FL) BICD2 as bait. Increasing amounts of recombinant Rab6aGTP (left) or Rab6aGDP (right) were added to the lysate, and the amount of endogenous dynein (dynein intermediate chain [DIC]) and dynactin (p150 subunit) bound was analyzed by immunoblot. (C) Sample kymographs of single-molecule DDB (aa 25–400 or FL BICD2) motility on microtubules. Fluorescence is from the N-terminal sfGFP tag on BICD2. (D) Quantification of the number of moving motors per micrometer of microtubule; mean and SEM from n = 3 independent experiments (each experiment measuring a minimum of 30 microtubules). (E) Quantification of number of moving motors per micrometer of microtubule of BICD2FL with either Rab6aGDP or Rab6aGTP added; mean and SEM from n = 3 independent experiments (each experiment measuring a minimum of 30 microtubules).